Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12
Description
Brief Summary
This study is intended to determine the positive predictive value (PPV) and negative
predictive value (NPV) of the multiprotein classifier based on the observed study prevalence
of Non-Small Cell Lung Cancer (NSCLC) in the study participants.
Detailed Description
Patients must present with previously non-diagnosed lung nodules as found on CT. There is no
change to the typical standard of care that any of the investigating physicians and/or
centers provide the patients enrolled in this study. The data from this study will not be
used to diagnose cancer nor be used to influence treatment decisions for the study
participants.
Phase
N/AInclusion and Exclusion Criteria
- Age ≥ 40 years
- Smoking history: Never, Former, Current
- Subject undergoing diagnostic evaluation for a lung nodule
- Subject undergoing evaluation for a lung nodule by a pulmonologist, and/or by a thoracic surgeon
- Baseline CT scan identifying lung nodule performed within 60 days of subject enrollment
- Nodule(s) identified by CT scan previously not followed
- Subject willing to provide informed consent for the collection of blood specimens
- Nodule work-up at the time of enrollment eligibility indicates any prior attempted or completed diagnostic biopsy procedure, such as transthoracic needle aspiration, bronchoscopic biopsy or surgery
- A prior CT scan is available that previously identifies the same lung nodule under consideration for study inclusion on the most current CT scan; AND the prior CT scan was performed more than 60 days before the current CT scan, irrespective of the candidate nodule's radiographic characterization such as size, density or appearance
- Current diagnosis of any cancer
- Prior diagnosis of any cancer within 2 years of lung nodule detection, except for non-melanoma skin cancer
- Administration of blood products, e.g. packed red blood cells, fresh frozen plasma, or platelets, within 30 days of subject enrollment
- History of human immunodeficiency virus (HIV) or Hepatitis C
Sites
-
California
- University of Southern California, Los Angeles, California, 90089
- University of Southern California, Los Angeles, California, 90089
- California Pacific Medical Center, San Francisco, California, 94115
- California Pacific Medical Center, San Francisco, California, 94115
-
Arizona
- St. Joseph's Hospital & Medical Center, Phoenix, Arizona, 85013
- St. Joseph's Hospital & Medical Center, Phoenix, Arizona, 85013
- Pulmonary Associates of Southern Arizona, Tucson, Arizona, 85712
- Pulmonary Associates of Southern Arizona, Tucson, Arizona, 85712
-
Oregon
- Oregon Clinic, Portland, Oregon, 97220
- Oregon Clinic, Portland, Oregon, 97220
-
Washington
- Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109
-
Texas
- Scott & White Clinic, Temple, Texas, 76508
- Scott & White Clinic, Temple, Texas, 76508
-
Minnesota
- Virginia Piper Cancer Institute - Allina Health, Minneapolis, Minnesota, 55407
- Virginia Piper Cancer Institute - Allina Health, Minneapolis, Minnesota, 55407
- Mayo Clinic, Rochester, Minnesota, 55901
- Mayo Clinic, Rochester, Minnesota, 55901
-
Missouri
- St. Luke's Medical Center, Chesterfield, Missouri, 63017
- St. Luke's Medical Center, Chesterfield, Missouri, 63017
-
Illinois
- Suburban Lung Associates, Elk Grove Village, Illinois, 60007
- Suburban Lung Associates, Elk Grove Village, Illinois, 60007
-
Tennessee
- Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37212
- Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37212
-
Kentucky
- Kentuckiana Pulmonary Associates, Louisville, Kentucky, 40202
-
Georgia
- Georgia Lung Associates, Austell, Georgia, 30106
- Georgia Lung Associates, Austell, Georgia, 30106
Powered by
SC CTSI